Anti-HSV-1 and anti-HIV-1 activity of gallic acid and pentyl gallate
Autor(a) principal: | |
---|---|
Data de Publicação: | 2008 |
Outros Autores: | , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
Texto Completo: | https://www.arca.fiocruz.br/handle/icict/28992 |
Resumo: | Universidade Federal de Santa Catarina. Departamento de Ciências Farmacêuticas. Laboratório de Virologia Aplicada, Florianópolis, SC, Brasil. |
id |
CRUZ_5b91f0cf5ba842699fa934c82aa923ef |
---|---|
oai_identifier_str |
oai:www.arca.fiocruz.br:icict/28992 |
network_acronym_str |
CRUZ |
network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
repository_id_str |
2135 |
spelling |
Kratz, Jadel MüllerAndrighetti-Fröhner, Carla ReginaKolling, Deise JulianaLeal, Paulo CésarSantos, Cláudio César CirneYunes, Rosendo AugustoNunes, Ricardo JoséTrybala, EdwardBergström, TomasFrugulhetti, Izabel C. P. P.Barardi, Célia Regina MonteSimões, Cláudia Maria Oliveira2018-09-22T20:58:54Z2018-09-22T20:58:54Z2008KRATZ, Jadel Müller; et al. Anti-HSV-1 and anti-HIV-1 activity of gallic acid and pentyl gallate. Mem Inst Oswaldo Cruz , v.103, n.5, p. 437-442, Aug. 2008.0074-0276https://www.arca.fiocruz.br/handle/icict/289921678-8060engFundação Oswaldo Cruz. Instituto Oswaldo Cruz.AntiviraisHIV-1Herpesvirus Humano 1Ácido GálicoantiviralHSV-1HIV-1gallic acidpentyl gallateAnti-HSV-1 and anti-HIV-1 activity of gallic acid and pentyl gallateinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleUniversidade Federal de Santa Catarina. Departamento de Ciências Farmacêuticas. Laboratório de Virologia Aplicada, Florianópolis, SC, Brasil.Universidade Federal de Santa Catarina. Departamento de Ciências Farmacêuticas. Laboratório de Virologia Aplicada, Florianópolis, SC, Brasil.Universidade Federal de Santa Catarina. Departamento de Ciências Farmacêuticas. Laboratório de Virologia Aplicada, Florianópolis, SC, Brasil / / Universidade Federal de Santa Catarina. Departamento de Química. Laboratório de Síntese e Estrutura-Atividade. Florianópolis, SC, Brasil / Universidade de Göteborg. Departamento de Virologia Clínica. Súecia..Universidade Federal de Santa Catarina. Departamento de Ciências Farmacêuticas. Laboratório de Virologia Aplicada, Florianópolis, SC, Brasil.Universidade Federal de Santa Catarina. Departamento de Química. Laboratório de Síntese e Estrutura-Atividade. Florianópolis, SC, Brasil.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunologia Clínica. Rio de Janeiro, RJ, Brasil.Universidade Federal de Santa Catarina. Departamento de Química. Laboratório de Síntese e Estrutura-Atividade. Florianópolis, SC, BrasilUniversidade Federal de Santa Catarina. Departamento de Química. Laboratório de Síntese e Estrutura-Atividade. Florianópolis, SC, BrasilUniversidade de Goteborg. Departamento de Virologia ClÍnica. Suécia.Universidade de Goteborg. Departamento de Virologia ClÍnica. Suécia.Universidade Federal Fluminense. Laboratório de Virologia Molecular, Departamento de Biologia Celular e Molecular. Niterói, RJ, Brasil.niversidade Federal de Santa Catarina. Campus Universitário Trindade. Departamento de Microbiologia e Parasitologia. Laboratório de Virologia Aplicada. Florianópolis, SC, Brasil.Universidade Federal de Santa Catarina. Departamento de Ciências Farmacêuticas. Laboratório de Virologia Aplicada, Florianópolis, SC, Brasil.The synthetic n-alkyl esters of gallic acid (GA), also known as gallates, especially propyl, octyl and dodecyl gallates, are widely employed as antioxidants by food and pharmaceutical industries. The inhibitory effects of GA and 15 gallates on Herpes Simplex Virus type 1 (HSV-1) and Human Immunodeficiency Virus (HIV-1) replication were investigated here. After a preliminary screening of these compounds, GA and pentyl gallate (PG) seemed to be the most active compounds against HSV-1 replication and their mode of action was characterized through a set of assays, which attempted to localize the step of the viral multiplication cycle where impairment occurred. The detected anti-HSV-1 activity was mediated by the inhibition of virus attachment to and penetration into cells, and by virucidal properties. Furthermore, an anti-HIV-1 activity was also found, to different degrees. In summary, our results suggest that both compounds could be regarded as promising candidates for the development of topical anti-HSV-1 agents, and further studies concerning the anti-HIV-1 activity of this group of molecules are merited.info:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/28992/1/license.txt5a560609d32a3863062d77ff32785d58MD51ORIGINALclaudio_cirnesantos_etal_IOC_2008.pdfclaudio_cirnesantos_etal_IOC_2008.pdfapplication/pdf443828https://www.arca.fiocruz.br/bitstream/icict/28992/2/claudio_cirnesantos_etal_IOC_2008.pdfe62a4fa6db160d85b8c73c47cb997ec7MD52TEXTclaudio_cirnesantos_etal_IOC_2008.pdf.txtclaudio_cirnesantos_etal_IOC_2008.pdf.txtExtracted texttext/plain32419https://www.arca.fiocruz.br/bitstream/icict/28992/3/claudio_cirnesantos_etal_IOC_2008.pdf.txt385a2af558067eb5d6da55f7b45949cbMD53icict/289922018-09-23 02:00:40.197oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352018-09-23T05:00:40Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.pt_BR.fl_str_mv |
Anti-HSV-1 and anti-HIV-1 activity of gallic acid and pentyl gallate |
title |
Anti-HSV-1 and anti-HIV-1 activity of gallic acid and pentyl gallate |
spellingShingle |
Anti-HSV-1 and anti-HIV-1 activity of gallic acid and pentyl gallate Kratz, Jadel Müller Antivirais HIV-1 Herpesvirus Humano 1 Ácido Gálico antiviral HSV-1 HIV-1 gallic acid pentyl gallate |
title_short |
Anti-HSV-1 and anti-HIV-1 activity of gallic acid and pentyl gallate |
title_full |
Anti-HSV-1 and anti-HIV-1 activity of gallic acid and pentyl gallate |
title_fullStr |
Anti-HSV-1 and anti-HIV-1 activity of gallic acid and pentyl gallate |
title_full_unstemmed |
Anti-HSV-1 and anti-HIV-1 activity of gallic acid and pentyl gallate |
title_sort |
Anti-HSV-1 and anti-HIV-1 activity of gallic acid and pentyl gallate |
author |
Kratz, Jadel Müller |
author_facet |
Kratz, Jadel Müller Andrighetti-Fröhner, Carla Regina Kolling, Deise Juliana Leal, Paulo César Santos, Cláudio César Cirne Yunes, Rosendo Augusto Nunes, Ricardo José Trybala, Edward Bergström, Tomas Frugulhetti, Izabel C. P. P. Barardi, Célia Regina Monte Simões, Cláudia Maria Oliveira |
author_role |
author |
author2 |
Andrighetti-Fröhner, Carla Regina Kolling, Deise Juliana Leal, Paulo César Santos, Cláudio César Cirne Yunes, Rosendo Augusto Nunes, Ricardo José Trybala, Edward Bergström, Tomas Frugulhetti, Izabel C. P. P. Barardi, Célia Regina Monte Simões, Cláudia Maria Oliveira |
author2_role |
author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Kratz, Jadel Müller Andrighetti-Fröhner, Carla Regina Kolling, Deise Juliana Leal, Paulo César Santos, Cláudio César Cirne Yunes, Rosendo Augusto Nunes, Ricardo José Trybala, Edward Bergström, Tomas Frugulhetti, Izabel C. P. P. Barardi, Célia Regina Monte Simões, Cláudia Maria Oliveira |
dc.subject.other.pt_BR.fl_str_mv |
Antivirais HIV-1 Herpesvirus Humano 1 Ácido Gálico |
topic |
Antivirais HIV-1 Herpesvirus Humano 1 Ácido Gálico antiviral HSV-1 HIV-1 gallic acid pentyl gallate |
dc.subject.en.pt_BR.fl_str_mv |
antiviral HSV-1 HIV-1 gallic acid pentyl gallate |
description |
Universidade Federal de Santa Catarina. Departamento de Ciências Farmacêuticas. Laboratório de Virologia Aplicada, Florianópolis, SC, Brasil. |
publishDate |
2008 |
dc.date.issued.fl_str_mv |
2008 |
dc.date.accessioned.fl_str_mv |
2018-09-22T20:58:54Z |
dc.date.available.fl_str_mv |
2018-09-22T20:58:54Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
KRATZ, Jadel Müller; et al. Anti-HSV-1 and anti-HIV-1 activity of gallic acid and pentyl gallate. Mem Inst Oswaldo Cruz , v.103, n.5, p. 437-442, Aug. 2008. |
dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/28992 |
dc.identifier.issn.pt_BR.fl_str_mv |
0074-0276 |
dc.identifier.eissn.none.fl_str_mv |
1678-8060 |
identifier_str_mv |
KRATZ, Jadel Müller; et al. Anti-HSV-1 and anti-HIV-1 activity of gallic acid and pentyl gallate. Mem Inst Oswaldo Cruz , v.103, n.5, p. 437-442, Aug. 2008. 0074-0276 1678-8060 |
url |
https://www.arca.fiocruz.br/handle/icict/28992 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. |
publisher.none.fl_str_mv |
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
collection |
Repositório Institucional da FIOCRUZ (ARCA) |
bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/28992/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/28992/2/claudio_cirnesantos_etal_IOC_2008.pdf https://www.arca.fiocruz.br/bitstream/icict/28992/3/claudio_cirnesantos_etal_IOC_2008.pdf.txt |
bitstream.checksum.fl_str_mv |
5a560609d32a3863062d77ff32785d58 e62a4fa6db160d85b8c73c47cb997ec7 385a2af558067eb5d6da55f7b45949cb |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
_version_ |
1813009233041424384 |